Meridian Investment Counsel Inc. Bristol Myers Squibb CO Transaction History

Meridian Investment Counsel Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $1,487 - $1,686	31 Added 0.58%	5,332 $289,000
Q1 2023 May 05, 2023	SELL	$65.71 - $74.53 $1,708 - $1,937	-26 Reduced 0.49%	5,301 $367,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $68 - $40,494	-527 Reduced 9.0%	5,327 $379,000
Q4 2019 Feb 06, 2020	BUY	$49.21 - $64.19 $288,075 - $375,768	5,854 New	5,854 $376,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Meridian Investment Counsel Inc., based on Form 13F filings with the SEC.

Stay updated on Meridian Investment Counsel Inc. with notifications on news.